IACCARINO, Guido
 Distribuzione geografica
Continente #
NA - Nord America 12.001
AS - Asia 9.122
EU - Europa 2.924
SA - Sud America 545
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 5
Totale 24.679
Nazione #
US - Stati Uniti d'America 11.928
HK - Hong Kong 6.420
SG - Singapore 978
CN - Cina 771
IT - Italia 705
UA - Ucraina 703
BR - Brasile 476
VN - Vietnam 390
RU - Federazione Russa 381
DE - Germania 363
IE - Irlanda 226
TR - Turchia 222
FI - Finlandia 179
KR - Corea 177
SE - Svezia 173
GB - Regno Unito 66
IN - India 46
CA - Canada 34
AR - Argentina 26
MX - Messico 26
PL - Polonia 26
NL - Olanda 24
BD - Bangladesh 22
JP - Giappone 21
EU - Europa 20
ZA - Sudafrica 19
AT - Austria 14
FR - Francia 14
EC - Ecuador 13
IQ - Iraq 12
ES - Italia 11
CZ - Repubblica Ceca 9
ID - Indonesia 9
PY - Paraguay 8
PK - Pakistan 7
UZ - Uzbekistan 7
VE - Venezuela 7
KE - Kenya 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
MA - Marocco 5
AZ - Azerbaigian 4
CH - Svizzera 4
CL - Cile 4
DO - Repubblica Dominicana 4
JO - Giordania 4
NP - Nepal 4
PE - Perù 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BH - Bahrain 3
CO - Colombia 3
DZ - Algeria 3
GH - Ghana 3
IL - Israele 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
SA - Arabia Saudita 3
SN - Senegal 3
TN - Tunisia 3
BB - Barbados 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
JM - Giamaica 2
LU - Lussemburgo 2
MK - Macedonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
YT - Mayotte 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
HN - Honduras 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MG - Madagascar 1
ML - Mali 1
NC - Nuova Caledonia 1
NE - Niger 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
SV - El Salvador 1
Totale 24.674
Città #
Hong Kong 6.414
Ann Arbor 2.883
Wilmington 2.392
Jacksonville 882
Woodbridge 854
Chandler 846
Princeton 691
Houston 571
Dallas 445
Dong Ket 307
Singapore 303
Ashburn 233
Dublin 225
Izmir 205
Nanjing 159
Andover 158
Boardman 157
Pellezzano 138
Mestre 135
Moscow 124
Beijing 108
Dearborn 97
Munich 88
Salerno 86
Düsseldorf 80
Los Angeles 79
Fairfield 71
Changsha 54
Shenyang 53
São Paulo 47
New York 46
Hebei 44
Falls Church 42
Nanchang 42
Ho Chi Minh City 35
Jiaxing 32
Saint Petersburg 32
Napoli 31
Norwalk 31
Turku 25
Rome 24
San Francisco 24
Tianjin 24
The Dalles 23
Venezia 23
Milan 22
San Diego 22
Warsaw 21
Santa Clara 20
Tokyo 20
Jinan 18
Montreal 18
Nuremberg 18
Brooklyn 17
Grevenbroich 17
London 17
Redwood City 17
Rio de Janeiro 17
Columbus 16
Hanoi 16
Naples 16
Cambridge 15
Guangzhou 15
Johannesburg 15
Phoenix 15
Denver 14
Washington 14
Pune 13
Seattle 12
Seoul 12
Stockholm 12
Charlotte 11
Lappeenranta 11
Manchester 11
Shanghai 11
Amsterdam 10
Boston 10
Council Bluffs 10
Poplar 10
Atlanta 9
Mexico City 9
Brasília 8
Buffalo 8
Salvador 8
Tappahannock 8
Bari 7
Belo Horizonte 7
Chennai 7
Helsinki 7
Mumbai 7
Tashkent 7
Ankara 6
Baghdad 6
Brno 6
Chicago 6
Curitiba 6
Guayaquil 6
Haikou 6
Lanzhou 6
New Delhi 6
Totale 20.022
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 846
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 836
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 544
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 497
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 482
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 403
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 395
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 291
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 270
Adrenergic signaling in heart failure and cardiovascular aging 260
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 259
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 251
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 246
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 246
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 231
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 231
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 225
Serum uric acid and left ventricular mass in essential hypertension 222
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 220
Thyroid function predicts increased cardiovascular risk 212
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 192
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 191
Characterization of a selective CaMKII peptide inhibitor 187
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 182
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 181
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 180
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 179
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 176
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 170
AKT participates in endothelial dysfunction in hypertension. 169
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 169
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 167
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 166
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 160
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 157
Targeting myocardial remodelling to develop novel therapies for heart failure 157
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 153
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 144
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 143
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 143
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 142
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 142
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 137
Active and Healthy Ageing and Independent Living 137
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 134
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 134
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 134
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 133
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 132
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 130
Active and Healthy Ageing and Independent Living 2016 130
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 130
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 128
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 128
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 125
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 124
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 124
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 124
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 123
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 123
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 121
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 121
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 121
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 120
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 120
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 120
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 119
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 119
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 118
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 118
G Protein-Coupled Receptor Kinases and Hypertension 117
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 117
Insufficient control of blood pressure and incident diabetes. 115
External support modulates G protein expression and receptor coupling in experimental vein grafts. 115
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 115
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. 114
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 114
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 112
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 111
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 111
Atrial fibrillation and microRNAs 111
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 110
Good at Heart: Preserving Cardiac Metabolism during aging 110
CaMK4 Gene Deletion Induces Hypertension 109
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. 107
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 107
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 106
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. 105
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 105
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 105
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor 105
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 105
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 104
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 104
Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. 103
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit. 103
GRK2 at the control shaft of cellular metabolism 103
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework 103
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 102
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 102
Totale 17.594
Categoria #
all - tutte 76.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.885


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.049 0 0 0 0 154 49 167 17 164 5 148 345
2021/20221.236 3 0 5 11 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/20268.342 1.316 3.436 2.799 475 316 0 0 0 0 0 0 0
Totale 25.124